Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arrhythmia Prevention in High Risk Cardiovascular Patients Using Targeted Potassium Levels

NCT03833089 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT03833089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03833089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arrhythmia Prevention in High Risk Cardiovascular Patients Using Targeted Potassium Levels
Lead sponsor
Rigshospitalet, Denmark
Phase
Phase 4
Overall status
Active, not recruiting
Start date
March 1, 2019
Completion date
April 1, 2035
Enrollment
1,200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, hyperkalemia, hypokalemia, implantable defibrillator user, ventricular arrhythmias and cardiac arrest, ventricular tachycardia